Development of factor VIII:C inhibitors following vaccination.
Ferri
G M
GM
Department of Medicina Clinica, University La Sapienza, Rome, Italy.
Vaccaro
F
F
Caccavo
D
D
Imperato
G
G
Bonomo
L
L
D001323:Autoantibodies / Q000097:blood*; D001500:BCG Vaccine / Q000276:immunology*; D003352:Corynebacterium / Q000276:immunology*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005169:Factor VIII / Q000276:immunology*; D005260:Female; D006801:Humans; D017512:Lichenoid Eruptions / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D014613:Vaccines, Attenuated / Q000276:immunology
D001323:Autoantibodies; D001500:BCG Vaccine; D014613:Vaccines, Attenuated; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin; D011241:Prednisone